Chicken interferon-induced transmembrane protein 1 promotes replication of coronavirus infectious bronchitis virus in a cell-specific manner

Vet Microbiol. 2022 Dec:275:109597. doi: 10.1016/j.vetmic.2022.109597. Epub 2022 Oct 28.

Abstract

Interferon-induced transmembrane proteins (IFITMs) are broad-spectrum antiviral proteins that inhibit numerous virus infections by impeding viral entry into target cells. However, increasing evidence suggests diverse functions of IFITMs in virus infection, especially with the coronavirus. We analyzed the effect of chicken interferon-induced transmembrane proteins (chIFITMs) on coronavirus infectious bronchitis virus (IBV) infection in vitro. We demonstrated that the antiviral effects of IFITMs are dependent on cell and virus types. The overexpression of chIFITM1 dramatically promoted the replication of IBV Beaudette strain in the chicken hepatocellular carcinoma cell line, LMH. Mechanistically, chIFITMs share roughly the same subcellular localization in different host cells, and overexpressed of chIFITM1 have no effect of viral attachment and entry. Further studies revealed that mutations of amino acids at key positions (60KSRD63, 68KDFV71) in the intracellular loop domain (CIL) caused loss of the promoted function. Interaction with downstream proteins in co-response to viral infection could be the primary reason behind variable functions of chIFITM1 in different cells. In all, our study explored the functions of chIFITMs in viral infection from a new perspective.

Keywords: Chicken virus; Coronavirus; IBV; IFITM; LMH.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Chickens
  • Coronavirus Infections* / veterinary
  • Infectious bronchitis virus* / genetics
  • Interferons / pharmacology
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Virus Replication

Substances

  • Antiviral Agents
  • Interferons
  • Membrane Proteins